![](https://news.europawire.eu/wp-content/uploads/2018/01/University-of-Warwick-biotechnology-firm-VirionHealth-receives-non-dilutive-funding-worth-up-to-4.2-million-from-the-US-Defense-Advanced-Research-Projects-Agency-DARPA-144x144.jpg)
Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA). … Read the full press release